Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension

@inproceedings{Kingman2017ManagementOP,
  title={Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension},
  author={Martha S Kingman and Christine L Archer-Chicko and Mary L Bartlett and Joy Beckmann and Robin Hohsfield and Sandra Lombardi},
  booktitle={Pulmonary circulation},
  year={2017}
}
Therapies that target the prostacyclin pathway are considered effective, yet are complex to dose and may cause dose-limiting side effects for patients with pulmonary arterial hypertension (PAH). Careful side effect management and the ability to discern side effects from worsening disease are essential in order for patients to continue, and benefit from, prostacyclin therapy. This manuscript was developed through a collaborative effort of allied health providers with extensive experience in… CONTINUE READING
0 Citations
40 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 40 references

The delphi process in the creation of a consensus statement for practical use of orenitram [abstract

  • FF Rahaghi, JP Feldman, RP Allen
  • Am J Respir Crit Care Med
  • 2015
Highly Influential
6 Excerpts

170–172

  • Berman-Rosenzweig E Horn E et al. Bloodstream infections among patie Barst R, 5608
  • (Available at: www.cdc.gov/mmwr/preview/mmwrhtml…
  • 2016
2 Excerpts

Actelion Pharmaceuticals US, Inc

  • UPTRAVI . South San Francisco
  • Available at: https://www. uptravi.com/pdf…
  • 2016

GlaxoSmithKline

  • NC FLOLAN . Research Triangle Park
  • Available at: www. gsksource.com/pharma/content…
  • 2016

Similar Papers

Loading similar papers…